Home › Trial NCT05285826
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
- Trial IDNCT05285826
- StatusActive Not Recruiting
- PhasePhase 3
- Study typeInterventional
- SponsorMerck Sharp & Dohme LLC
- Enrollment8100
- Start date2022-02-18
- ConditionsPapillomavirus Infections
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.